« Previous
Next »
The American Journal of Medicine
Volume 122, Issue 3
, Pages
265-272
, March 2009
B-Type Natriuretic Peptides for the Evaluation of Exercise Intolerance
-
Receiver operating characteristic (ROC) curves for the ability of B-type natriuretic peptide (BNP) and N-terminal-pro-B-type-natriuretic peptide (NT-proBNP) measured at rest to detect a cardiocirculat
Receiver operating characteristic (ROC) curves for the ability of B-type natriuretic peptide (BNP) and N-terminal-pro-B-type-natriuretic peptide (NT-proBNP) measured at rest to detect a cardiocirculatory limitation. The area under the ROC curve (AUC) with 95% confidence interval (CI) is given.
-
Receiver operating characteristic (ROC) curves for the ability of B-type natriuretic peptide (BNP) and N-terminal-pro-B-type-natriuretic peptide (NT-proBNP) measured at peak exercise to detect a cardiReceiver operating characteristic (ROC) curves for the ability of B-type natriuretic peptide (BNP) and N-terminal-pro-B-type-natriuretic peptide (NT-proBNP) measured at peak exercise to detect a cardiocirculatory limitation. The area under the ROC curve (AUC) with 95% confidence interval (CI) is given.
Funding: CM (Grant PP00B-102853) and MTM (Grant PBZHB-121007) are supported by the Swiss National Science Foundation.
Conflicts of Interest: Dr. Mueller has received research support from Abbott, Biosite, Brahms, and Roche as well as speaker's honoraria from Abbott, Bayer, Biosite, Brahms, and Roche Diagnostic. The other authors have no possible conflicts of interest to declare. Diagnostic reagents were provided by Roche Diagnostics (Basel, Switzerland) and Abbott (Zug, Switzerland). The sponsors had no role in study design, data analysis, or interpretation.
Authorship: All authors had access to the data and played a role in writing this manuscript.
PII: S0002-9343(08)00986-8
doi: 10.1016/j.amjmed.2008.08.030
© 2009 Elsevier Inc. All rights reserved.
« Previous
Next »
The American Journal of Medicine
Volume 122, Issue 3
, Pages
265-272
, March 2009

